Drug Profile
Valrocemide
Alternative Names: SPD 493; TV 1901; TVP 1901; Valproyl glycinamide; VGDLatest Information Update: 15 Jan 2019
Price :
$50
*
At a glance
- Originator Hebrew University of Jerusalem
- Class Antiepileptic drugs; Neuroprotectants
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued CNS disorders; Epilepsy
Most Recent Events
- 08 Jan 2019 Shire has been acquired and merged into Takeda
- 21 Feb 2008 Discontinued - Phase-I for CNS disorders in USA (PO)
- 09 Mar 2007 Phase-I clinical trials in CNS disorders in USA (PO)